The company's same-store occupancy is above pre-COVID levels, with potential for further growth driven by higher acuity care demand. They embed state supplemental payments in their Medicaid rates and anticipate consistent performance. M&A activity is accelerated by regulatory changes, with a focus on distressed opportunities.